Publications by authors named "James A Hendrix"

Claim this Profile
W
Weight management recommendations for youth with Down syndrome: Expert recommendations.
Lauren T Ptomey, Nicolas M Oreskovic, James A Hendrix, Dominica Nichols, Stamatis Agiovlasitis

Front Pediatr· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Examining older adults with neuroatypical conditions for MCI/dementia: Barriers and recommendations of the Neuroatypical Conditions Expert Consultative Panel.
Matthew P Janicki, James A Hendrix, Philip McCallion,

Alzheimers Dement (Amst)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-Sectional Exploration of Plasma Biomarkers of Alzheimer's Disease in Down Syndrome: Early Data from the Longitudinal Investigation for Enhancing Down Syndrome Research (LIFE-DSR) Study.
James A Hendrix, David C Airey, Angela Britton, Anna D Burke, George T Capone, Suzanne Hendrix

J Clin Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opportunities, barriers, and recommendations in down syndrome research.
James A Hendrix, Angelika Amon, Leonard Abbeduto, Stamatis Agiovlasitis, Tarek Alsaied

Transl Sci Rare Dis· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a symptom menu to facilitate Goal Attainment Scaling in adults with Down syndrome-associated Alzheimer's disease: a qualitative study to identify meaningful symptoms.
Kari Knox, Justin Stanley, James A Hendrix, Hampus Hillerstrom, Taylor Dunn

J Patient Rep Outcomes· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing combination therapy for Alzheimer's disease.
Stephen P Salloway, Jeff Sevingy, Kumar Budur, Jan Torleif Pederson, Ronald B DeMattos, James A Hendrix

Alzheimers Dement (N Y)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need.
Ganesh M Babulal, Yakeel T Quiroz, Benedict C Albensi, Eider Arenaza-Urquijo, Arlene J Astell, James A Hendrix

Alzheimers Dement· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease.
Leslie M Shaw, Jalayne Arias, Kaj Blennow, Douglas Galasko, Jose Luis Molinuevo, James A Hendrix

Alzheimers Dement· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital technologies as biomarkers, clinical outcomes assessment, and recruitment tools in Alzheimer's disease clinical trials.
Michael Gold, Joan Amatniek, Maria C Carrillo, Jesse M Cedarbaum, James A Hendrix

Alzheimers Dement (N Y)· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable.
David S Knopman, Samantha Budd Haeberlein, Maria C Carrillo, James A Hendrix, Geoff Kerchner

Alzheimers Dement· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
National Institute on Aging - Alzheimer's Association Research Framework lays the groundwork for deeper understanding of Alzheimer's disease.
David S Knopman, Eric R Siemers, Lisa J Bain, James A Hendrix, Maria C Carrillo

Alzheimers Dement· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring cognition and function in the preclinical stage of Alzheimer's disease.
Sandra Weintraub, Maria C Carrillo, Sarah Tomaszewski Farias, Terry E Goldberg, James A Hendrix

Alzheimers Dement (N Y)· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential roles of digital technologies in clinical trials.
Sara Czaja, Michael Gold, Lisa J Bain, James A Hendrix, Maria C Carrillo

Alzheimers Dement· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms.
Krista L Lanctôt, Joan Amatniek, Sonia Ancoli-Israel, Steven E Arnold, Clive Ballard, James A Hendrix

Alzheimers Dement (N Y)· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is cognitive decline measurable in preclinical Alzheimer's disease?
Sandra Weintraub, Christopher Randolph, Lisa Bain, James A Hendrix, Maria C Carrillo

Alzheimers Dement· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple comorbid neuropathologies in the setting of Alzheimer's disease neuropathology and implications for drug development.
Gil D Rabinovici, Maria C Carrillo, Mark Forman, Susan DeSanti, David S Miller, James A Hendrix

Alzheimers Dement (N Y)· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines to improve animal study design and reproducibility for Alzheimer's disease and related dementias: For funders and researchers.
Heather M Snyder, Diana W Shineman, Lauren G Friedman, James A Hendrix, Ara Khachaturian

Alzheimers Dement· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tau: From research to clinical development.
David M Holtzman, Maria C Carrillo, James A Hendrix, Lisa J Bain, Ana M Catafau

Alzheimers Dement· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Considering new treatment paradigms for neuropsychiatric symptoms of Alzheimer's disease.
Krista L Lanctôt, Brendon P Boot, Lisa J Bain, James A Hendrix, Maria C Carrillo

Alzheimers Dement· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The roles of inflammation and immune mechanisms in Alzheimer's disease.
Linda J Van Eldik, Maria C Carrillo, Patricia E Cole, Dominik Feuerbach, Barry D Greenberg, James A Hendrix

Alzheimers Dement (N Y)· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges, solutions, and recommendations for Alzheimer's disease combination therapy.
James A Hendrix, Randall J Bateman, H Robert Brashear, Cynthia Duggan, Maria C Carrillo

Alzheimers Dement· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Worldwide Alzheimer's Disease Neuroimaging Initiative: An update.
James A Hendrix, Brad Finger, Michael W Weiner, Giovanni B Frisoni, Takeshi Iwatsubo

Alzheimers Dement· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of a novel series of histamine H3 receptor antagonists through a scaffold hopping strategy.
Zhongli Gao, William J Hurst, Daniel Hall, Ryan Hartung, William Reynolds, James A Hendrix

Bioorg Med Chem· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and profiling of 3,5-dimethyl-isoxazole-4-carboxylic acid [2-methyl-4-((2S,3'S)-2-methyl-[1,3']bipyrrolidinyl-1'-yl)phenyl] amide as histamine H(3) receptor antagonist for the treatment of depression.
Zhongli Gao, William J Hurst, Werngard Czechtizky, Daniel Hall, Nicolas Moindrot, James A Hendrix

Bioorg Med Chem Lett· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a potent, selective, and orally bioavailable histamine H3 receptor antagonist SAR110068 for the treatment of sleep-wake disorders.
Zhongli Gao, William J Hurst, Werngard Czechtizky, Dominique Francon, Guy Griebel, James A Hendrix

Bioorg Med Chem Lett· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis